10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 377,061 | 344,067 | 398,159 | 379,824 | 355,781 |
| Marketable Securities | 49,844 | 49,335 | N/A | 269 | 16,033 |
| Receivables | 52,549 | 88,468 | 83,525 | 91,178 | 91,305 |
| Inventories | 74,710 | 83,107 | 94,050 | 88,272 | 83,189 |
| TOTAL | $579,730 | $584,387 | $593,893 | $579,155 | $567,093 |
| Non-Current Assets | |||||
| PPE Net | 246,087 | 252,648 | 258,759 | 263,285 | 269,486 |
| Intangibles | 19,703 | 20,182 | 20,660 | 21,169 | 20,640 |
| Other Non-Current Assets | 57,873 | 61,419 | 64,482 | 66,059 | 65,694 |
| TOTAL | $323,663 | $334,249 | $343,901 | $350,513 | $355,820 |
| Total Assets | $903,393 | $918,636 | $937,794 | $929,668 | $922,913 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,068 | 12,909 | 26,210 | 21,248 | 20,216 |
| Accrued Expenses | 67,440 | 74,780 | 67,850 | 62,515 | 63,094 |
| TOTAL | $107,900 | $117,633 | $121,235 | $111,019 | $108,733 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20,949 | 20,658 | 17,760 | 16,436 | 14,296 |
| Other Non-Current Liabilities | 76,029 | 78,356 | 81,406 | 83,233 | 85,559 |
| TOTAL | $88,598 | $90,869 | $93,755 | $94,591 | $95,346 |
| Total Liabilities | $196,498 | $208,502 | $214,990 | $205,610 | $204,079 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,134 | 122,302 | 121,054 | 120,491 | 119,708 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,501,405 | -1,467,047 | -1,418,019 | -1,382,266 | -1,344,369 |
| Other shareholders' equity | -367 | -493 | 32 | -430 | -456 |
| TOTAL | $706,895 | $710,134 | $722,804 | $724,058 | $718,834 |
| Total Liabilities And Equity | $903,393 | $918,636 | $937,794 | $929,668 | $922,913 |